Expression ofSLC22A1variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib
Journal article published in 2013 by
Elisa Herraez 
,
Elisa Lozano,
Rocio I. R. Macias,
Javier Vaquero ,
Luis Bujanda,
Jesus M. Banales ,
Jose J. G. Marin,
Oscar Briz
,
Elisa Lozano,
Rocio I. R. Macias,
Javier Vaquero ,
Luis Bujanda,
Jesus M. Banales ,
Jose J. G. Marin,
Oscar Briz
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 